Bianchi, D. W. et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 314, 162–169 (2015).
Article CAS PubMed Google Scholar
Dharajiya, N. G. et al. Incidental detection of maternal neoplasia in noninvasive prenatal testing. Clin. Chem. 64, 329–335 (2018).
Article CAS PubMed Google Scholar
Ji, X. et al. Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests. Genet. Med. 21, 2293–2302 (2019).
Lenaerts, L. et al. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies. eClinicalMedicine 35, 100856 (2021).
Article PubMed PubMed Central Google Scholar
Goldring, G. et al. Maternal malignancy after atypical findings on single-nucleotide polymorphism-based prenatal cell-free DNA screening. Obstet. Gynecol. 141, 791–800 (2023).
Article CAS PubMed PubMed Central Google Scholar
Heesterbeek, C. J. et al. Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study. J. Clin. Oncol. 40, 2426–2435 (2022).
Heesterbeek, C. J. et al. Comprehensive recommendations for the clinical management of pregnant women with noninvasive prenatal test results suspicious of a maternal malignancy. JCO Oncol. Pract. https://doi.org/10.1200/op.23.00594 (2024).
Rink, B. D., Stevens, B. K. & Norton, M. E. Incidental detection of maternal malignancy by fetal cell-free DNA screening. Obstet. Gynecol. 140, 121–131 (2022).
Article CAS PubMed Google Scholar
Norton, M. E. et al. Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results. Am. J. Obstet. Gynecol. 229, 300.e301–300.e309 (2023).
Dow, E. et al. Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model. JCO Precis. Oncol. 5, 1001–1012 (2021).
留言 (0)